mortality

February 29, 2016May 13, 2016

Ofev (Nintedanib) Slows IPF Disease Progression, According to Analysis of Studies

An analysis of the Phase II TOMORROW trial and two Phase III INPULSIS trials (INPULSIS-1 and INPULSIS-2), analyzing the safety and efficacy outcomes for Ofev (nintedanib, developed by Boehringer Ingelheim), revealed that ... Read more

February 15, 2016February 18, 2016

In Certain People with PAH, Researchers Identify Markers for Lower Mortality Rates

News, Pulmonary Hypertension, Scleroderma

A new study demonstrated that specific antibodies could be markers for decreased mortality in people with connective tissue disease and systemic sclerosis associated with pulmonary arterial hypertension (PAH). The report in ... Read more

February 15, 2016May 13, 2016

Air Pollution Can Lead to Life-Threatening Lung Disease 30 Years Later, Study Finds

Chronic Bronchitis, Emphysema, News, Pneumonia

Exposure to air pollution more than 30 years ago can impact an individual’s current risk of dying of respiratory disease, according to a report from the MRC-PHE Center for Environment and Health, Imperial College ... Read more

January 4, 2016January 4, 2016

Behavioral and Socialdemographic Factors Influence Racial/Ethnic Differences in Lung Cancer Incidence and Mortality

Lung Cancer, News

In a new study, researchers investigated race and ethnic influences on lung cancer incidence and mortality among women, and found that differences in lung cancer diagnosis and survival outcomes were ... Read more

August 6, 2015November 5, 2015

Serum Autoantibodies Profile Not a Biomarker for Survival in Systemic Sclerosis-PAH Patients

News, Pulmonary Hypertension

In a new study entitled “Survival in systemic sclerosis–pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry,” the authors ... Read more

June 4, 2015November 5, 2015

Model to Predict IPF Mortality Used Successfully in Systemic Sclerosis-Associated Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis, News

Researchers at the University of British Columbia in Canada recently reported that mortality prediction models used in patients with idiopathic pulmonary fibrosis (IPF) can also be employed to assess short-term ... Read more